Transcatheter Aortic Valve Replacement (TAVR) Market Share, Size, Trends & Analysis By Type, Region Insights, Key Players, Applications and Forecast to 2028

  • Category:Pharmaceuticals & Healthcare
  • Published on:Apr 2020
  • Pages:103
  • Formats:
  • Report Code:24222

Report Summary

Eternity Insights has published a new study on Global Transcatheter Aortic Valve Replacement (TAVR) Market focusing on key segments as by Type (Transfemoral Approach,Transapical Approach,Others), by Application (Aortic Stenosis,Aortic Regurgitation,Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Transcatheter Aortic Valve Replacement (TAVR) Market.

The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.

Transcatheter Aortic Valve Replacement (TAVR) Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.

Global Transcatheter Aortic Valve Replacement (TAVR) Market Size, 2018-2028 (USD Million)

To learn more about this report

Request For Sample

Global Transcatheter Aortic Valve Replacement (TAVR) Market Segmentation:

Transcatheter Aortic Valve Replacement (TAVR) Market, By Type

  • Transfemoral Approach
  • Transapical Approach
  • Others

Transcatheter Aortic Valve Replacement (TAVR) Market, By Application

  • Aortic Stenosis
  • Aortic Regurgitation
  • Other

To learn more about this report

Request For Sample

Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Transcatheter Aortic Valve Replacement (TAVR) market in terms of demand generation. The Transcatheter Aortic Valve Replacement (TAVR) market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Transcatheter Aortic Valve Replacement (TAVR) market for below listed coun-tries across each region.

North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).

Global Transcatheter Aortic Valve Replacement (TAVR) Market Taxonomy:

To learn more about this report

Request For Sample

Global Transcatheter Aortic Valve Replacement (TAVR) Market Competitive Landscape

The global Transcatheter Aortic Valve Replacement (TAVR) market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details

  • Company Overview
  • Financial Analysis
  • Product Portfolio Analysis
  • Strategic Overview
  • SWOT Analysis

List of Companies Profiled in the report:

  • Edwards Lifesciences
  • Medtronic
  • St. Jude Medical
  • Boston Scientific
  • Meril Life Sciences
  • Bracco (HLT)
  • JenaValve Technology
  • Other Players of Specific Interest can be added based on requirement

Market Segmentation

Report Attributes Details
The market size value in 2021 USD XX.XX Million
CAGR (2021 - 2028) XX.XX %
The Revenue forecast in 2028 USD XX.XX Million
Base year for estimation 2021
Historical data 2018-2019
Forecast period 2022-2028
Quantitative units
  • Revenue in USD Million
  • CAGR from 2021 to 2028
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered By Type Outlook, Application Outlook, Regional Outlook
By Type Outlook Transfemoral Approach,Transapical Approach,Others
By Application Outlook Aortic Stenosis,Aortic Regurgitation,Other
Regional scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country scope U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey
Key companies profiled Edwards Lifesciences,Medtronic,St. Jude Medical,Boston Scientific,Meril Life Sciences,Bracco (HLT),JenaValve Technology
Customization Available Yes, the report can be tailored to meet your specific requirements.

Key Benefits to the stake holders

  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come

Table Of Contents

Table of Contents

Global Transcatheter Aortic Valve Replacement (TAVR) Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Transcatheter Aortic Valve Replacement (TAVR) Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Transfemoral Approach Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Transapical Approach Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 Others Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Transcatheter Aortic Valve Replacement (TAVR) Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Transcatheter Aortic Valve Replacement (TAVR) Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Transcatheter Aortic Valve Replacement (TAVR) Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Transcatheter Aortic Valve Replacement (TAVR) Market Assessment by Type
8.1 Asia Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Assessment by Application (Consumption and Market Share)
8.2 North America Transcatheter Aortic Valve Replacement (TAVR) Market Assessment by Application (Consumption and Market Share)
8.3 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Assessment by Application (Consumption and Market Share)
8.4 South America Transcatheter Aortic Valve Replacement (TAVR) Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Edwards Lifesciences
9.1.1 Edwards Lifesciences Profiles
9.1.2 Edwards Lifesciences Product Portfolio
9.1.3 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Business Performance
9.1.4 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Business Development and Market Status
9.2 Medtronic
9.2.1 Medtronic Profiles
9.2.2 Medtronic Product Portfolio
9.2.3 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Business Performance
9.2.4 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Business Development and Market Status
9.3 St. Jude Medical
9.3.1 St. Jude Medical Profiles
9.3.2 St. Jude Medical Product Portfolio
9.3.3 St. Jude Medical Transcatheter Aortic Valve Replacement (TAVR) Business Performance
9.3.4 St. Jude Medical Transcatheter Aortic Valve Replacement (TAVR) Business Development and Market Status
9.4 Boston Scientific
9.4.1 Boston Scientific Profiles
9.4.2 Boston Scientific Product Portfolio
9.4.3 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Business Performance
9.4.4 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Business Development and Market Status
9.5 Meril Life Sciences
9.5.1 Meril Life Sciences Profiles
9.5.2 Meril Life Sciences Product Portfolio
9.5.3 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Business Performance
9.5.4 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Business Development and Market Status
9.6 Bracco (HLT)
9.6.1 Bracco (HLT) Profiles
9.6.2 Bracco (HLT) Product Portfolio
9.6.3 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Business Performance
9.6.4 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Business Development and Market Status
9.7 JenaValve Technology
9.7.1 JenaValve Technology Profiles
9.7.2 JenaValve Technology Product Portfolio
9.7.3 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Business Performance
9.7.4 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Business Development and Market Status
10 World Transcatheter Aortic Valve Replacement (TAVR) Market Assessment by Players
10.1 Global Transcatheter Aortic Valve Replacement (TAVR) Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Transcatheter Aortic Valve Replacement (TAVR) Price (USD/Unit) of Players 2014-2020
10.4 Global Transcatheter Aortic Valve Replacement (TAVR) Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Transcatheter Aortic Valve Replacement (TAVR) Sales Assessment of Players 2014-2020
11.1.2 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue Assessment of Players 2014-2020
11.1.3 North America Transcatheter Aortic Valve Replacement (TAVR) Price Assessment of Players 2014-2020
11.1.4 North America Transcatheter Aortic Valve Replacement (TAVR) Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Assessment of Players 2014-2020
11.2.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Transcatheter Aortic Valve Replacement (TAVR) Price Assessment of Players 2014-2020
11.2.4 Europe Transcatheter Aortic Valve Replacement (TAVR) Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Transcatheter Aortic Valve Replacement (TAVR) Sales Assessment of Players 2014-2020
11.4.2 South America Transcatheter Aortic Valve Replacement (TAVR) Revenue Assessment of Players 2014-2020
11.4.3 South America Transcatheter Aortic Valve Replacement (TAVR) Price Assessment of Players 2014-2020
11.4.4 South America Transcatheter Aortic Valve Replacement (TAVR) Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Transcatheter Aortic Valve Replacement (TAVR) Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Transcatheter Aortic Valve Replacement (TAVR) Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Transcatheter Aortic Valve Replacement (TAVR) Sales by Countries/Regions 2014-2020
12.2.2 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Countries/Regions 2014-2020
12.2.3 North America Transcatheter Aortic Valve Replacement (TAVR) Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Sales by Countries/Regions 2014-2020
12.3.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Countries/Regions 2014-2020
12.3.3 Europe Transcatheter Aortic Valve Replacement (TAVR) Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Transcatheter Aortic Valve Replacement (TAVR) Sales by Countries/Regions 2014-2020
12.4.2 South America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Countries/Regions 2014-2020
12.4.3 South America Transcatheter Aortic Valve Replacement (TAVR) Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Transcatheter Aortic Valve Replacement (TAVR) Sales & Revenue Forecast 2021-2026
14.1 World Transcatheter Aortic Valve Replacement (TAVR) Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Transcatheter Aortic Valve Replacement (TAVR)Sales and Market Share by Regions
14.1.2 World Transcatheter Aortic Valve Replacement (TAVR)Revenue and Market Share by Regions
15 Asia Transcatheter Aortic Valve Replacement (TAVR) Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Transfemoral Approach
15.1.2 Transapical Approach
15.1.3 Others
15.2 Consumption Forecast by Application, 2021-2026
16 North America Transcatheter Aortic Valve Replacement (TAVR) Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Transfemoral Approach
16.1.2 Transapical Approach
16.1.3 Others
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Transfemoral Approach
17.1.2 Transapical Approach
17.1.3 Others
17.2 Consumption Forecast by Application, 2021-2026
18 South America Transcatheter Aortic Valve Replacement (TAVR) Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Transfemoral Approach
18.1.2 Transapical Approach
18.1.3 Others
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Transfemoral Approach
19.1.2 Transapical Approach
19.1.3 Others
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Transcatheter Aortic Valve Replacement (TAVR) Price (USD/Unit) Trend 2021-2026
20.2 Global Transcatheter Aortic Valve Replacement (TAVR) Gross Profit Trend 2021-2026
21 Conclusion


Choose License Type

close

categories